Download PDF
CC BY-NC-ND 4.0 · Indian J Radiol Imaging 2024; 34(03): 405-415
DOI: 10.1055/s-0043-1777993
Original Article

Radiomics-Based Machine Learning Classification Strategy for Characterization of Hepatocellular Carcinoma on Contrast-Enhanced Ultrasound in High-Risk Patients with LI-RADS Category M Nodules

Lingling Li   #
1   Department of Ultrasound, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China
,
Xiaoxin Liang   #
1   Department of Ultrasound, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China
,
Yiwen Yu
1   Department of Ultrasound, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China
,
Rushuang Mao
1   Department of Ultrasound, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China
,
Jing Han
1   Department of Ultrasound, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China
,
Chuan Peng   *
1   Department of Ultrasound, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China
,
Jianhua Zhou   *
1   Department of Ultrasound, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China
› Author Affiliations Funding None.
› Further Information
Also available at
   Permissions and Reprints

Abstract

Objective Accurate differentiation within the LI-RADS category M (LR-M) between hepatocellular carcinoma (HCC) and non-HCC malignancies (mainly intrahepatic cholangiocarcinoma [CCA] and combined hepatocellular and cholangiocarcinoma [cHCC-CCA]) is an area of active investigation. We aimed to use radiomics-based machine learning classification strategy for differentiating HCC from CCA and cHCC-CCA on contrast-enhanced ultrasound (CEUS) images in high-risk patients with LR-M nodules.

Methods A total of 159 high-risk patients with LR-M nodules (69 HCC and 90 CCA/cHCC-CCA) who underwent CEUS within 1 month before pathologic confirmation from January 2006 to December 2019 were retrospectively included (111 patients for training set and 48 for test set). The training set was used to build models, while the test set was used to compare models. For each observation, six CEUS images captured at predetermined time points (T1, peak enhancement after contrast injection; T2, 30 seconds; T3, 45 seconds; T4, 60 seconds; T5, 1–2 minutes; and T6, 2–3 minutes) were collected for tumor segmentation and selection of radiomics features, which included seven types of features: first-order statistics, shape (2D), gray-level co-occurrence matrix, gray-level size zone matrix, gray-level run length matrix, neighboring gray tone difference matrix, and gray-level dependence matrix. Clinical data and key radiomics features were employed to develop the clinical model, radiomics signature (RS), and combined RS-clinical (RS-C) model. The RS and RS-C model were built using the machine learning framework. The diagnostic performance of these three models was calculated and compared.

Results Alpha-fetoprotein (AFP), CA19-9, enhancement pattern, and time of washout were included as independent factors for clinical model (all p < 0.05). Both the RS and RS-C model performed better than the clinical model in the test set (area under the curve [AUC] of 0.698 [0.571–0.812] for clinical model, 0.903 [0.830–0.970] for RS, and 0.912 [0.838–0.977] for the RS-C model; both p < 0.05).

Conclusions Radiomics-based machine learning classifiers may be competent for differentiating HCC from CCA and cHCC-CCA in high-risk patients with LR-M nodules.

Keywords

contrast-enhanced ultrasound - LI-RADS category M - hepatocellular carcinoma - machine learning

# These authors contributed equally to this work.


* These are co-corresponding authors.


Supplementary Material



Publication History

Article published online:
17 January 2024

© 2024. Indian Radiological Association. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Llovet JM, Zucman-Rossi J, Pikarsky E. et al. Hepatocellular carcinoma. Nat Rev Dis Primers 2016; 2 (16018): 16018
    CrossrefPubMedGoogle Scholar
  • 2 Heimbach JK, Kulik LM, Finn RS. et al. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology 2018; 67 (01) 358-380
    CrossrefPubMedGoogle Scholar
  • 3 European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu. European Association for the Study of the Liver. EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 2018; 69 (01) 182-236
    CrossrefPubMedGoogle Scholar
  • 4 American College of Radiology website. CEUS LI-RADS 2017 Core. 2017 . Accessed March 22, 2022 at: www.acr.org/-/media/ACR/Files/RADS/LI-RADS/CEUS-LI-RADS-2017-Core.pdf
    PubMedGoogle Scholar
  • 5 Zheng W, Li Q, Zou XB. et al. Evaluation of contrast-enhanced US LI-RADS version 2017: application on 2020 liver nodules in patients with hepatitis B infection. Radiology 2020; 294 (02) 299-307
    CrossrefPubMedGoogle Scholar
  • 6 Terzi E, Iavarone M, Pompili M. et al; CEUS LI-RADS Italy study group collaborators. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter retrospective study of 1,006 nodules. J Hepatol 2018; 68 (03) 485-492
    CrossrefPubMedGoogle Scholar
  • 7 Rodgers SK, Fetzer DT, Kono Y. Using LI-RADS with contrast-enhanced ultrasound. Clin Liver Dis (Hoboken) 2021; 17 (03) 154-158
    CrossrefPubMedGoogle Scholar
  • 8 Chernyak V, Fowler KJ, Kamaya A. et al. Liver Imaging Reporting and Data System (LI-RADS) version 2018: imaging of hepatocellular carcinoma in at-risk patients. Radiology 2018; 289 (03) 816-830
    CrossrefPubMedGoogle Scholar
  • 9 Lambin P, Leijenaar RTH, Deist TM. et al. Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol 2017; 14 (12) 749-762
    CrossrefPubMedGoogle Scholar
  • 10 Limkin EJ, Sun R, Dercle L. et al. Promises and challenges for the implementation of computational medical imaging (radiomics) in oncology. Ann Oncol 2017; 28 (06) 1191-1206
    CrossrefPubMedGoogle Scholar
  • 11 Lee SH, Park H, Ko ES. Radiomics in breast imaging from techniques to clinical applications: a review. Korean J Radiol 2020; 21 (07) 779-792
    CrossrefPubMedGoogle Scholar
  • 12 Peng J, Kang S, Ning Z. et al. Residual convolutional neural network for predicting response of transarterial chemoembolization in hepatocellular carcinoma from CT imaging. Eur Radiol 2020; 30 (01) 413-424
    CrossrefPubMedGoogle Scholar
  • 13 Li L, Hu Y, Han J, Li Q, Peng C, Zhou J. Clinical application of liver imaging reporting and data system for characterizing liver neoplasms: a meta-analysis. Diagnostics (Basel) 2021; 11 (02) 323
    CrossrefPubMedGoogle Scholar
  • 14 Shin J, Lee S, Bae H. et al. Contrast-enhanced ultrasound liver imaging reporting and data system for diagnosing hepatocellular carcinoma: A meta-analysis. Liver Int 2020; 40 (10) 2345-2352
    CrossrefPubMedGoogle Scholar
  • 15 Chernyak V, Fowler KJ, Do RKG. et al. LI-RADS: looking back, looking forward. Radiology 2023; 307 (01) e222801
    CrossrefPubMedGoogle Scholar
  • 16 Kim JH, Ko ES, Lim Y. et al. Breast cancer heterogeneity: MR imaging texture analysis and survival outcomes. Radiology 2017; 282 (03) 665-675
    CrossrefPubMedGoogle Scholar
  • 17 Ganeshan B, Goh V, Mandeville HC, Ng QS, Hoskin PJ, Miles KA. Non-small cell lung cancer: histopathologic correlates for texture parameters at CT. Radiology 2013; 266 (01) 326-336
    CrossrefPubMedGoogle Scholar
  • 18 Fujima N, Homma A, Harada T. et al. The utility of MRI histogram and texture analysis for the prediction of histological diagnosis in head and neck malignancies. Cancer Imaging 2019; 19 (01) 5
    CrossrefPubMedGoogle Scholar
  • 19 Mokrane FZ, Lu L, Vavasseur A. et al. Radiomics machine-learning signature for diagnosis of hepatocellular carcinoma in cirrhotic patients with indeterminate liver nodules. Eur Radiol 2020; 30 (01) 558-570
    CrossrefPubMedGoogle Scholar
  • 20 Peng Y, Lin P, Wu L. et al. Ultrasound-based radiomics analysis for preoperatively predicting different histopathological subtypes of primary liver cancer. Front Oncol 2020; 10: 1646
    CrossrefPubMedGoogle Scholar